Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment.
about
Novel Drugs and Combination Therapies for the Treatment of Metastatic MelanomaThe calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapseInhibiting STAT3 signaling is involved in the anti-melanoma effects of a herbal formula comprising Sophorae Flos and Lonicerae Japonicae FlosEfficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: A systematic review and meta-analysis of randomized controlled trialsSpotlight on pembrolizumab in the treatment of advanced melanoma.Muc1 promotes migration and lung metastasis of melanoma cells.Effects of nuclear factor-κB and ERK signaling transduction pathway inhibitors on human melanoma cell proliferation in vitro.Serpine2, a potential novel target for combating melanoma metastasisInto the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapyThe oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors.Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors.A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting.The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches.Editorial: "Cancer Immunotherapy: Lights and Shadows".Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factorsImmunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous MelanomaThe dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermiaDendritic cell therapy in melanoma.Case report on the role of radiofrequency-assisted spleen-preserving surgery for splenic metastasis in the era of check-point inhibitors.Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature.
P2860
Q26772015-09391BFE-BC0B-467F-AF16-E8C21C137937Q27317001-287674CF-8BB2-4064-8FEE-247A066A2C0BQ27329598-72DEDF1A-4F8A-4FBD-8F56-8C3E911F46A7Q33780055-0496F359-323B-44C6-A1B3-EEB75F081416Q33879794-7177B3FD-2A61-472B-8B69-1E7FC7CF53B8Q35703777-F3464E71-8C92-4B0B-854C-500245ECD69CQ36250595-DDF12146-867C-4F52-A8BB-C97812437084Q36336131-59424946-D979-49A3-82BE-97A0F4AF49C8Q36964051-AA124BE8-84A2-45FD-832E-B26B7700617BQ37267785-14D635C8-515E-436C-BF15-5DC9B4D197CDQ38260167-2651D2F5-1EEB-4AF0-8A1B-4B4BA772EA8DQ38716324-954D97F8-059E-4F88-90EB-E2709046ECD3Q38753120-2542E7E7-4CE0-407B-9C7E-265E5617D457Q38968155-4F18CF46-6EE0-48E5-B583-F7DACC77B548Q39100049-D21B0CF1-3533-4863-81F7-383FAE7A35BDQ41326480-539082D3-C689-40D7-8774-3EBDCC5C7336Q42323429-E83A6576-159E-4797-B797-3F3C9B9235D6Q42362520-C4C1C380-763D-4E3A-B888-73564D29A638Q42427640-57AEBBD3-1EDC-4B6E-A2C8-3E312F7AFD45Q43923587-BFBC3C13-2699-478D-BC44-7B89B48E589FQ47149194-AA209A79-DEDC-4F56-B52D-EFE7DE4B8797Q55025685-30CF8318-EBBC-47EC-8C06-BC888941E035
P2860
Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Combining immunotherapy with o ...... w road for melanoma treatment.
@ast
Combining immunotherapy with o ...... w road for melanoma treatment.
@en
type
label
Combining immunotherapy with o ...... w road for melanoma treatment.
@ast
Combining immunotherapy with o ...... w road for melanoma treatment.
@en
prefLabel
Combining immunotherapy with o ...... w road for melanoma treatment.
@ast
Combining immunotherapy with o ...... w road for melanoma treatment.
@en
P2860
P356
P1476
Combining immunotherapy with o ...... w road for melanoma treatment.
@en
P2093
Mariana Aris
María Marcela Barrio
P2860
P356
10.3389/FIMMU.2015.00046
P577
2015-02-09T00:00:00Z